Indiva Reports Record Market Share for January 2021
09 2월 2021 - 9:00PM
Indiva Limited (the “
Company” or
“
Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading
Canadian producer of cannabis edibles, is pleased to announce
record market share for the month of January. Indiva’s edible
products continue to lead, as demonstrated by strong sell through
data from Hifyre, and from the OCS, for the month of January.
Estimated market share across the three largest
markets of British Columbia, Alberta, and Ontario expanded from 43%
in December to 44% share of sales in January, as Indiva again
increased its lead in the #1 market share position in the edibles
category:
-
Ontario #1 with 43% market share. Note: OCS data put Indiva market
share in the Edibles category at 41.5% for January.
- Alberta #1 with
45% market share.
- British Columbia
#1 with 47% market share.
- Manitoba #1 with
46% market share.
- Yukon #1 with
55% market share.
- Saskatchewan
market share declined to 16% in the month of January due to a
transition away from the current wholesale/distribution
partner.
- As of February,
Indiva edible products became available in the Northwest
Territories, bringing distribution across Canada to seven provinces
and two territories.
- Wana™ Sour
Gummies led the Gummies category with 30% market share overall in
edibles across the three largest provinces, a sequential monthly
increase in market share of 2%.
- Bhang® continued
to lead the chocolate category, with Bhang® Milk Chocolate
remaining the top selling chocolate edible SKU nationally.
- Product ranking
in January again showed the top three SKUs overall in the edible
category continue to be Wana™ Sour Gummies (led by
Strawberry-Lemonade 1:1).
- In January, four
of the top five, and seven of the top 10 ranking edible SKUs are
from Indiva.
“We are very pleased that Indiva’s edible
products continue to rank at the top of the category and gain
market share, despite several new entrants and products becoming
available,” said Niel Marotta, President and Chief Executive
Officer of Indiva. “Indiva looks forward to continuing to bring new
and innovative best-in-class edible products to of-age Canadian
consumers, with additional new products expected to be unveiled and
launched in market nationally in the month of March.”
COVID-19Government and private
entities are still assessing the present and future effects of the
COVID-19 pandemic. Indiva has continued to operate with enhanced
health and safety protocols in place to protect its employees. The
Company continues to assess the customer, supply chain, and
staffing implications of COVID-19 and is committed to making
continuous adjustments to minimize disruption and impact. Indiva
will remain proactive in its response to the pandemic and compliant
with any and all provincial and/or federal policy enacted to
protect Canadians.
ABOUT INDIVA
Indiva sets the standard for quality and
innovation in cannabis. As a Canadian licensed producer, Indiva
creates premium pre-rolls, flower, capsules, and edible products
and provides production and manufacturing services to peer
entities. In Canada, Indiva produces and distributes the
award-winning Bhang® Chocolate, Wana™ Sour Gummies, Ruby® Cannabis
Sugar, Sapphire™ Cannabis Salt, Artisan Batch, and other Powered by
INDIVA™ products through license agreements and partnerships. Click
here to connect with Indiva on LinkedIn, Instagram, Twitter
and Facebook, and here to find more information on the Company and
its products.
CONTACTSINVESTOR CONTACTAnthony
SimonePhone: 416-881-5154Email: ir@indiva.com
DISCLAIMER AND READER
ADVISORY
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) has in any way passed upon
the merits of the contents of this press release and neither of the
foregoing entities accepts responsibility for the adequacy or
accuracy of this release or has in any way approved or disapproved
of the contents of this press release.
Certain statements contained in this press
release constitute forward-looking information. These statements
relate to future events or future performance. The use of any of
the words “could”, “intend”, “expect”, “believe”, “will”,
“projected”, “estimated” and similar expressions and statements
relating to matters that are not historical facts are intended to
identify forward-looking information and are based on the parties’
current belief or assumptions as to the outcome and timing of such
future events. Actual future results may differ materially. In
particular, this release contains forward-looking information
relating to the Company's future operations, future product
offerings and compliance with applicable regulations. Various
assumptions or factors are typically applied in drawing conclusions
or making the forecasts or projections set out in forward-looking
information. Those assumptions and factors are based on information
currently available to the parties. The material factors and
assumptions include the parties being able to maintain the
necessary regulatory and other third parties’ approvals and
licensing and other risks associated with regulated entities in the
cannabis industry. The forward-looking information contained in
this release is made as of the date hereof and the parties are not
obligated to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise,
except as required by applicable securities laws. Because of the
risks, uncertainties and assumptions contained herein, investors
should not place undue reliance on forward looking information. The
foregoing statements expressly qualify any forward-looking
information contained herein.
This press release does not constitute an offer
to sell or a solicitation of an offer to buy any of the securities
in the United States. The securities have not been and will not be
registered under the United States Securities Act of 1933, as
amended (the “U.S. Securities Act”) or any state securities laws
and may not be offered or sold within the United States or to U.S.
Persons unless registered under the U.S. Securities Act and
applicable state securities laws or an exemption from such
registration is available. Not for distribution to U.S. Newswire
Services or for dissemination in the United States. Any failure to
comply with this restriction may constitute a violation of U.S.
Securities laws.
Indiva (TSXV:NDVA)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Indiva (TSXV:NDVA)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025